T2 Biosystems (NASDAQ:TTOO – Get Rating) will release its earnings data after the market closes on Monday, May 15th. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
T2 Biosystems Stock Performance
TTOO opened at $0.28 on Friday. T2 Biosystems has a fifty-two week low of $0.26 and a fifty-two week high of $15.00. The firm’s fifty day moving average is $0.42 and its 200 day moving average is $1.12. The stock has a market cap of $5.72 million, a price-to-earnings ratio of -0.02 and a beta of 0.35.
Analyst Ratings Changes
Separately, StockNews.com started coverage on shares of T2 Biosystems in a research note on Sunday, May 7th. They set a “sell” rating on the stock. One analyst has rated the stock with a sell rating and four have issued a hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $2.50.
Institutional Trading of T2 Biosystems
About T2 Biosystems
T2 Biosystems, Inc engages in the development of a proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables detection of pathogens, biomarkers, and other abnormalities in a range of unpurified patient sample types. The firm’s products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel.
- Get a free copy of the StockNews.com research report on T2 Biosystems (TTOO)
- An Updraft Is Brewing For DraftKings
- PepsiCo Hits “Sweet Spot” For APAC Growth, Macros Agree
- High-Risk Mullen Automotive Continues To Build Momentum
- 3 Recession-Proof Stocks With Nice Dividends
- Oracle Stock Climbs For Third Month, Still In Buy Range
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.